| 名称 |
品牌 |
货号 |
规格 |
价格 |
|---|
Phorbol |
Cayman |
24479-1mg |
1 mg |
970.901,022.00
|
Kisspeptin-54 (human) (trifluoroacetate salt) |
Cayman |
24477-500µg |
500 µg |
8,551.909,002.00
|
MSH Release-Inhibiting Factor (trifluoroacetate salt) |
Cayman |
24476-50mg |
50 mg |
4,216.104,438.00
|
MSH Release-Inhibiting Factor (trifluoroacetate salt) |
Cayman |
24476-25mg |
25 mg |
2,380.702,506.00
|
MSH Release-Inhibiting Factor (trifluoroacetate salt) |
Cayman |
24476-100mg |
100 mg |
6,317.506,650.00
|
MSH Release-Inhibiting Factor (trifluoroacetate salt) |
Cayman |
24476-10mg |
10 mg |
1,077.301,134.00
|
[Nle4,D-Phe7]-α-MSH (trifluoroacetate salt) |
Cayman |
24475-1mg |
1 mg |
2,207.802,324.00
|
C6 Glucosylceramide (d18:2/6:0) |
Cayman |
24474-5mg |
5 mg |
6,157.906,482.00
|
N-Glycine Glucosylsphingosine (d18:1) |
Cayman |
24473-1mg |
1 mg |
5,266.805,544.00
|
C6 Biotin Galactosylceramide (d18:1/6:0) |
Cayman |
24471-5mg |
5 mg |
8,059.808,484.00
|
C12 Lissamine-rhodamine Galactosylceramide (d18:1/12:0) |
Cayman |
24470-500µg |
500 µg |
6,317.506,650.00
|
C18 Galactosylceramide-d35 (d18:1/18:0-d35) |
Cayman |
24467-5mg |
5 mg |
询价
|
C15 Galactosylceramide (d18:1/15:0) |
Cayman |
24466-5mg |
5 mg |
2,513.702,646.00
|
C2 Galactosylceramide (d18:1/2:0) |
Cayman |
24465-10mg |
10 mg |
3,497.903,682.00
|
C18 Ceramide-1-phosphate-d3 (d18:1/18:0-d3) |
Cayman |
24464-1mg |
1 mg |
询价
|
Lysodihydrosphingomyelin (d18:0) |
Cayman |
24463-1mg |
1 mg |
3,019.103,178.00
|
MCH (human, mouse, rat) (trifluoroacetate salt) |
Cayman |
24462-1mg |
1 mg |
5,027.405,292.00
|
LL-37 (human) (trifluoroacetate salt) |
Cayman |
24461-500µg |
500 µg |
2,274.302,394.00
|
LL-37 (human) (trifluoroacetate salt) |
Cayman |
24461-1mg |
1 mg |
4,282.604,508.00
|
GLP-1 (1-37) (human, rat, mouse, bovine) (trifluoroacetate s |
Cayman |
24460-500µg |
500 µg |
2,846.202,996.00
|